ALC:NYSE
Alcon AG
73,87 USD
arrow_downward
-0,35%(-0,26) 1D
16-ноя., 12:13:33 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
74,35 USD
High
74,76 USD
Low
73,87 USD
Mkt. cap
31,19 млд
Avg. vol.
2,14 млн
Volume
534,03 миң
52-wk high
87,64 USD
52-wk low
61,84 USD
Beta
0,87
Shares outstanding
483,40 млн
No. of employees
25 миң
Open
74,35 USD
High
74,76 USD
Low
73,87 USD
Mkt. cap
31,19 млд
Avg. vol.
2,14 млн
Volume
534,03 миң
52-wk high
87,64 USD
52-wk low
61,84 USD
Beta
0,87
Shares outstanding
483,40 млн
No. of employees
25 миң
News stories
From web sources and news partners
Benzinga
·
1 саат мурун
Here’s How Much You Would Have Made Owning iShares S&P 500 Growth ETF Stock In The Last 15 Years
24/7 Wall St.
·
6 мүнөт мурун
S&P 500 Drops 1.1% at Midday as Nasdaq Leads the Selloff
Trading News
·
10 мүнөт мурун
Stock Market Today: S&P 500 SPX (7,562) 7,812 Target, Nasdaq, Dow, NVDA -3.7%
Traders Union
·
2 саат мурун
Morgan Stanley lifts S&P 500 target to 8,700 for 2027
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25 миң
Founded1945
HeadquartersЖенева, Женева, Швейцария
SectorHealth Care
IndustryMedical device
Websitealcon.com